NAFDAC approves Pfizer-BioTech coronavirus vaccine for use in Nigeria

The National Agency for Food and Drug Administration and Control, NAFDAC, on Friday approved the use of Pfizer COVID-19 vaccine in Nigeria.

This is coming few months after it gave authorisation for the use of the Oxford-Astrazeneca jabs in the country.

READ ALSO: Investment Expert begs IMF to extend debt service relief to NigeriaAnnouncing this at a press conference in Lagos, the Director-General of NAFDAC, Mojisola Adeyeye  explained that the pfizer-Bio Tech vaccine was for emergency use only.

She added that the vaccine can now be stored between -15 to-25  equivalent to freezer temperature.